ARTV vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

ARTV

60.5
AI Score
VS
ARTV Wins

CBIO

36.8
AI Score

Investment Advisor Scores

ARTV

61score
Recommendation
HOLD

CBIO

37score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ARTV CBIO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -100.0% 0.0% CBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 60.5/100 36.8/100 ARTV
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY ARTV

Relative Price Performance (Last 90 Days)

ARTV 1M: -33.8% · 3M: -65.8% CBIO 1M: +13.4% · 3M: -19.1%

Current Technical Phase

ARTV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -28.6%), weak momentum, RSI 23

RSI (14): 22.6 · Price: $4.01

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.4 · Price: $14.15

Fundamentals Snapshot

Metric ARTV CBIO
Market Cap — —
Forward P/E -2.0 -5.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -1.0% 0.0%
Gross Margin — 1.0%
Operating Margin 0.0% -14.3%
EPS -2.85 -7.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ARTV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.